Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices 46997 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIDDK. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Diabetes and 

Digestive and Kidney Diseases, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: October 15–16, 2009. 

Time: October 15, 2009, 8:15 a.m. to 3:50 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 9S235, Bethesda, MD 20892. 

Time: October 16, 2009, 8:15 a.m. to 4:45 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 9S235 Bethesda, MD 20892. 

Contact Person: Ira W. Levin, PhD, 

Director, Division of Intramural Research, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, NIH, Bethesda, MD 

20892, 301–496–6844, iwl@helix.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–21997 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Cell Bank. 

Date: October 8, 2009. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20814 (Telephone 

Conference Call). 

Contact Person: Alicja L Markowska, PhD, 

DSC, Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

7201 Wisconsin Avenue, Suite 2C212, 

Bethesda, MD 20892. 301–496–9666. 

markowska@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Genetics of 

Aging in Drosophila. 

Date: October 20, 2009. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Building, Suite 2C212, MSC–9205, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7707. elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, 

Neuroendocrine and Reproductive Aging. 

Date: December 2, 2009. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact Person: Rebecca J. Ferrell, PhD, 

Scientific Review Officer, National Institute 

on Aging, Gateway Building 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7703. ferrellrj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–21999 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Safety and Occupational Health Study 

Section (SOHSS), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC announces the 

following meeting of the 

aforementioned committee: 

Times and Dates: 8 a.m.–5 p.m., October 

13, 2009 (Closed). 8 a.m.–5 p.m., October 14, 

2009 (Closed). 

Place: Embassy Suites Hotel, 1900 

Diagonal Road, Alexandria, Virginia 22314, 

Telephone (703) 684–5900, Fax (703) 684– 

1403. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Purpose: The Safety and Occupational 

Health Study section will review, discuss, 

and evaluate grant application(s) received in 

response to the Institute’s standard grants 

review and funding cycles pertaining to 

research issues in occupational safety and 

health, and allied areas. 

It is the intent of NIOSH to support broadbased research endeavors in keeping with the 

Institute’s program goals. This will lead to 

improved understanding and appreciation for 

the magnitude of the aggregate health burden 

associated with occupational injuries and 

illnesses, as well as to support more focused 

research projects, which will lead to 

improvements in the delivery of occupational 

safety and health services, and the 

prevention of work-related injury and illness. 

It is anticipated that research funded will 

promote these program goals. 


cprice-sewell on DSK2BSOYB1PROD with NOTICES
46998 Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices 

Matters to be Discussed: The meeting will 

convene to address matters related to the 

conduct of Study section business and for the 

study section to consider safety and 

occupational health-related grant 

applications. Agenda items are subject to 

change as priorities dictate. 

Contact Person for More Information: Price 

Connor, PhD, NIOSH Health Scientist, 1600 

Clifton Road, NE., Mailstop E–20, Atlanta, 

Georgia 30333, Telephone (404) 498–2511, 

Fax (404) 498–2571. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 3, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–21991 Filed 9–11–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Public 

Forums 

Notice is hereby given of two forums 

of the working groups of the NIH 

Scientific Management Review Board: 

Deliberating Organizational Changes 

and Effectiveness Working Group and 

Substance Use, Abuse and Addition 

Working Group. The forums will serve 

as the first among a series of sessions for 

gathering information on the agency’s 

organizational structure and 

recommendations for enhancing the 

NIH mission through greater agency 

flexibility and responsiveness. 

The forums will be open to the public, 

with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The input from these meetings will be 

summarized in a report that will be 

presented to the Scientific Management 

Review Board in open session at an 

upcoming meeting. 

Name of Committee: Substance Use, 

Abuse, and Addiction Working Group of the 

Scientific Management Review Board. 

Date: September 23, 2009. 

Open: 8 a.m. to 3 p.m. 

Agenda: Presentation and discussion will 

include an overview of the science of 

substance use, abuse, and addiction and the 

public health needs in this area of research. 

Place: National Institutes of Health, 

Building 60, Chapel and Lecture Hall, 9000 

Rockville Pike, Bethesda, MD 20892. 

Name of Committee: Deliberating 

Organizational Change and Effectiveness 

Working Group of the Scientific Management 

Review Board. 

Date: September 24, 2009. 

Open: 8 a.m. to 3 p.m. 

Agenda: Presentations and discussion will 

include an overview of NIH mission and 

function from scientific and stakeholder 

perspectives, including elaboration upon the 

principles and attributes fundamental to its 

success. 

Place: National Institutes of Health, 

Building 60, Chapel and Lecture Hall, 9000 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Dr. Lyric Jorgenson, PhD, 

NIH–AAAS Science and Technology Policy 

Fellow, Office of Science Policy, Office of the 

Director, NIH, National Institutes of Health, 

Building 1, Room 218, MSC 0166, 9000 

Rockville Pike, Bethesda, MD 20892, 

smrb@mail.nih.gov, (301) 496–6837. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. The 

meeting will also be webcast. The draft 

meeting agenda and other information about 

the SMRB, including information about 

access to the webcast, will be available at 

http://smrb.od.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Dated: August 28, 2009. 

Lynn Hudson, 

Acting Director, Office of Biotechnology 

Activities. 

[FR Doc. E9–22000 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Child Health and Human Development 

Council, September 21, 2009, 8 a.m. to 

September 21, 2009, 5 p.m., National 

Institutes of Health, Building 31, 31 

Center Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on September 1, 2009, 74 FR 

54224. 

This notice is being amended to 

provide additional attendee viewing and 

Videocast access instructions for open 

session of Council. In order to facilitate 

public attendance at the open session of 

Council, reserve seating will be made 

available to the first five individuals 

reserving seats in the main meeting 

room, Conference Room 6. Please 

Contact Ms. Lisa Kaeser, Program and 

Public Liaison Office, NICHD, at 301– 

496–0536 to make your reservation. 

Additional seating will be available in 

the meeting overflow rooms, Conference 

Rooms 7 and 8. Individuals will also be 

able to view the meeting via NIH 

Videocast. Please go to the following 

link for Videocast access instructions at: 

http://www.nichd.nih.gov/about/ 

overview/advisory/nachhd/virtualmeeting-200910.cfm. The meeting is 

partially closed to the public. 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–21998 Filed 9–11–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0667] 

[FDA 225–09–0010] 

Memorandum of Understanding With 

Duke University 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the Food 

and Drug Administration and Duke 

University. The purpose of this MOU is 

to establish a framework for 

collaboration between the Parties and 

for pursuing specific collaborative 

projects. This collaboration between the 

Parties shall be known as the Cardiac 

Safety Research Consortium. 

DATES: The agreement became effective 

August 4, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Wendy R. Sanhai, Office of the 

Commissioner (HZ–1), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–7867, 

FAX: 301–827–5891. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 


cprice-sewell on DSK2BSOYB1PROD with NOTICES